Burges Salmon advised biotech company Nodus Oncology on the deal. Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets...
Burges Salmon advised biotech company Nodus Oncology on the deal. Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets...
You must be a Standard 1 Year member to access this content.